We are live on
!
Find out more
N
Nuveen Portfolio holdings
AUM
$369B
1-Year Est. Return
31.66%
This Fund
S&P 500
This Quarter
Est. Return
+9.78%
1 Year Est. Return
+31.66%
3 Year Est. Return
+110.02%
5 Year Est. Return
+148.02%
10 Year Est. Return
+492.84%
AUM
$258B
AUM Growth
+$11.2B
(+4.5%)
Cap. Flow
-$8.74B
Cap. Flow
% of AUM
-3.39%
Top 10 Holdings %
Top 10 Hldgs %
19.2%
Holding
3,329
New
40
Increased
1,011
Reduced
1,987
Closed
159
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Prologis
PLD
|
+$352M |
| 2 |
Merck
MRK
|
+$333M |
| 3 |
NVIDIA
NVDA
|
+$306M |
| 4 |
Atlassian
TEAM
|
+$280M |
| 5 |
Corteva
CTVA
|
+$253M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alnylam Pharmaceuticals
ALNY
|
+$3.41B |
| 2 |
Alphabet (Google) Class C
GOOG
|
+$331M |
| 3 |
iShares Russell 1000 Growth ETF
IWF
|
+$266M |
| 4 |
Danaher
DHR
|
+$240M |
| 5 |
TWTR
Twitter, Inc.
TWTR
|
+$237M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.56% |
| 2 | Healthcare | 14.16% |
| 3 | Financials | 12.95% |
| 4 | Consumer Discretionary | 9.77% |
| 5 | Industrials | 9.07% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1
Microsoft
MSFT
$2.84T
| $13.4B | 5.21% |
56,021,384
+336,061
| +0.6% | +$80.6M |
|
2
Apple
AAPL
$4.89T
| $10.7B | 4.16% |
82,632,552
-77,671
| -0.1% | -$11.1M |
|
3
Amazon
AMZN
$2.5T
| $5.12B | 1.98% |
60,896,592
-956,139
| -2% | -$94.4M |
|
4
UnitedHealth
UNH
$382B
| $3.84B | 1.49% |
7,238,550
-37,509
| -0.5% | -$19.9M |
|
5
Mastercard
MA
$477B
| $2.95B | 1.14% |
8,479,903
-492,146
| -5% | -$162M |
|
|
6
Alphabet (Google) Class C
GOOG
$3.9T
| $2.81B | 1.09% |
31,697,742
-3,468,520
| -10% | -$331M |
|
|
7
Alphabet (Google) Class A
GOOGL
$3.91T
| $2.78B | 1.08% |
31,505,481
-2,110,104
| -6% | -$201M |
|
8
Visa
V
$677B
| $2.76B | 1.07% |
13,285,716
-660,356
| -5% | -$133M |
|
9
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
$34.7B
| $2.63B | 1.02% |
24,989,576
| – | – |
|
|
10
NVIDIA
NVDA
$5.01T
| $2.46B | 0.95% |
168,179,290
+20,870,830
| +14% | +$306M |
|
11
Broadcom
AVGO
$1.82T
| $2.34B | 0.91% |
41,770,620
-2,754,810
| -6% | -$138M |
|
12
Nuveen Growth Opportunities ETF
NUGO
$2.41B
| $2.09B | 0.81% |
119,252,279
-8,474,831
| -7% | -$151M |
|
13
JPMorgan Chase
JPM
$939B
| $2.05B | 0.79% |
15,262,262
-344,521
| -2% | -$43.7M |
|
14
AbbVie
ABBV
$458B
| $2B | 0.77% |
12,353,578
-1,212,368
| -9% | -$186M |
|
15
Tesla
TSLA
$1.24T
| $1.99B | 0.77% |
16,165,596
+636,540
| +4% | +$121M |
|
16
Home Depot
HD
$332B
| $1.98B | 0.77% |
6,270,166
+158,281
| +3% | +$48.2M |
|
17
PepsiCo
PEP
$186B
| $1.98B | 0.77% |
10,957,069
+108,119
| +1% | +$19.3M |
|
18
Procter & Gamble
PG
$343B
| $1.94B | 0.75% |
12,802,668
+519,844
| +4% | +$72.9M |
|
19
Johnson & Johnson
JNJ
$635B
| $1.93B | 0.75% |
10,919,920
-794,610
| -7% | -$137M |
|
20
Berkshire Hathaway Class B
BRK.B
$1.07T
| $1.93B | 0.75% |
6,231,896
-206,681
| -3% | -$61.4M |
|
21
Costco
COST
$415B
| $1.91B | 0.74% |
4,193,003
+216,894
| +5% | +$106M |
|
22
Chevron
CVX
$388B
| $1.9B | 0.74% |
10,563,355
+609,807
| +6% | +$106M |
|
23
Eli Lilly
LLY
$1.07T
| $1.84B | 0.71% |
5,036,164
-98,034
| -2% | -$34.8M |
|
|
24
Merck
MRK
$324B
| $1.81B | 0.7% |
16,280,521
+3,262,048
| +25% | +$333M |
|
25
ExxonMobil
XOM
$651B
| $1.78B | 0.69% |
16,171,339
-94,797
| -0.6% | -$10.2M |
|
Similar funds
VFT
Nuveen's Q4 2022 Portfolio in Review
As of Q4 2022, Nuveen held 3,329 positions worth $258B, up 4.5% from $247B the previous quarter. Its ten largest holdings account for 19% of the portfolio.
Nuveen withdrew a net $8.74B in Q4 2022, closing 159 positions and reducing 1,987 holdings. Its most notable exit was Twitter, Inc., an estimated $237M position sold in full.
By sector, the portfolio is most concentrated in Technology at 23% of assets, down from 23% a quarter earlier, followed by Healthcare and Financials.
Against the trend, Nuveen opened a new position in Atlassian worth $226M.
- Nuveen's largest Q4 2022 buy was Atlassian: 1,759,716 shares worth $226M.
- Nuveen added most to Prologis in Q4 2022, an estimated $352M increase.
- Nuveen's biggest Q4 2022 reduction was Alnylam Pharmaceuticals, cutting an estimated $3.41B.
- Nuveen fully exited Twitter, Inc. in Q4 2022, selling an estimated $237M.
- Nuveen's ten largest holdings make up 19% of its $258B portfolio in Q4 2022.
- Nuveen opened 40 new positions and closed 159 in Q4 2022.
- Nuveen's portfolio value rose 4.5% quarter-over-quarter to $258B.
Based on Nuveen's 13F filing for Q4 2022, filed 14 Feb 2023.